dc.contributor.author |
Win, Shwe Sin |
|
dc.contributor.author |
Camargo, Carlos A |
|
dc.contributor.author |
Khaw, Kay-Tee |
|
dc.contributor.author |
Lawes, Carlene MM |
|
dc.contributor.author |
Sluyter, John |
|
dc.contributor.author |
Waayer, Debbie |
|
dc.contributor.author |
Toop, Les |
|
dc.contributor.author |
Scragg, Robert |
|
dc.coverage.spatial |
England |
|
dc.date.accessioned |
2021-09-26T23:23:09Z |
|
dc.date.available |
2021-09-26T23:23:09Z |
|
dc.date.issued |
2019-4 |
|
dc.identifier.issn |
0960-0760 |
|
dc.identifier.uri |
https://hdl.handle.net/2292/56676 |
|
dc.description.abstract |
<h4>Background</h4>Previous studies, mostly with children, have reported inconsistent findings on the associations of vitamin D status with asthma prevalence, exacerbations, and control. Because of limited research with adults, we examined these associations in a large community-based sample of New Zealand adults.<h4>Methods</h4>5110 participants, aged 50-84 years, were recruited from the community into a clinical trial of vitamin D supplementation. The current analysis is based on baseline blood sample collection to measure serum 25-hydroxyvitamin D (25(OH)D), which was deseasonalized for data analyses; and baseline asthma assessment, which included questions on asthma prevalence, urgent medical care for asthma in the previous 12 months, and control of asthma symptoms in the previous 4 weeks.<h4>Results</h4>702 (13.2%) of 5088 participants reported having doctor-diagnosed asthma. There was no difference in mean (SE) 25(OH)D concentration between participants with and without asthma: 66 (0.9) and 66 (0.4) nmol/L, respectively, adjusting for sex (p = 0.71). However, in multivariable analyses restricted to participants who reported having asthma, mean (SE) 25(OH)D concentration was 6.3 (2.6) nmol/L lower in those who reported having urgent medical care for asthma in the previous 12 months compared to others (p = 0.02), and 10.4 (3.9) nmol/L lower in those with very poor asthma control compared to those who were well-controlled (p = 0.03).<h4>Conclusion</h4>These cross-sectional results suggest that asthmatic adults with lower vitamin D status are more likely to receive urgent asthma medical care and to experience poor asthma control. Clinical trials are needed to determine the role of vitamin D supplementation in asthma management. |
|
dc.format.medium |
Print-Electronic |
|
dc.language |
eng |
|
dc.publisher |
Elsevier BV |
|
dc.relation.ispartofseries |
The Journal of steroid biochemistry and molecular biology |
|
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
|
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
|
dc.subject |
Humans |
|
dc.subject |
Asthma |
|
dc.subject |
Vitamin D Deficiency |
|
dc.subject |
Vitamins |
|
dc.subject |
Vitamin D |
|
dc.subject |
Ambulatory Care |
|
dc.subject |
Prevalence |
|
dc.subject |
Cross-Sectional Studies |
|
dc.subject |
Aged |
|
dc.subject |
Aged, 80 and over |
|
dc.subject |
Middle Aged |
|
dc.subject |
New Zealand |
|
dc.subject |
Female |
|
dc.subject |
Male |
|
dc.subject |
25-Hydroxyvitamin D |
|
dc.subject |
Asthma |
|
dc.subject |
Asthma control |
|
dc.subject |
Asthma exacerbations |
|
dc.subject |
Cross-sectional survey |
|
dc.subject |
Vitamin D |
|
dc.subject |
Aged |
|
dc.subject |
Aged, 80 and over |
|
dc.subject |
Ambulatory Care |
|
dc.subject |
Asthma |
|
dc.subject |
Cross-Sectional Studies |
|
dc.subject |
Female |
|
dc.subject |
Humans |
|
dc.subject |
Male |
|
dc.subject |
Middle Aged |
|
dc.subject |
New Zealand |
|
dc.subject |
Prevalence |
|
dc.subject |
Vitamin D |
|
dc.subject |
Vitamin D Deficiency |
|
dc.subject |
Vitamins |
|
dc.subject |
Science & Technology |
|
dc.subject |
Life Sciences & Biomedicine |
|
dc.subject |
Biochemistry & Molecular Biology |
|
dc.subject |
Endocrinology & Metabolism |
|
dc.subject |
25-Hydroxyvitamin D |
|
dc.subject |
Asthma |
|
dc.subject |
Asthma control |
|
dc.subject |
Asthma exacerbations |
|
dc.subject |
Cross-sectional survey |
|
dc.subject |
Vitamin D |
|
dc.subject |
25-HYDROXYVITAMIN D LEVELS |
|
dc.subject |
D DEFICIENCY |
|
dc.subject |
ADOLESCENTS |
|
dc.subject |
ATOPY |
|
dc.subject |
SUPPLEMENTATION |
|
dc.subject |
1117 Public Health and Health Services |
|
dc.subject |
1102 Cardiorespiratory Medicine and Haematology |
|
dc.subject |
Clinical |
|
dc.subject |
Public Health |
|
dc.subject |
Nutrition |
|
dc.subject |
Lung |
|
dc.subject |
Asthma |
|
dc.subject |
Clinical Research |
|
dc.subject |
Complementary and Alternative Medicine |
|
dc.subject |
Respiratory |
|
dc.subject |
0301 Analytical Chemistry |
|
dc.subject |
0601 Biochemistry and Cell Biology |
|
dc.title |
Cross-sectional associations of vitamin D status with asthma prevalence, exacerbations, and control in New Zealand adults. |
|
dc.type |
Journal Article |
|
dc.identifier.doi |
10.1016/j.jsbmb.2018.11.016 |
|
pubs.begin-page |
1 |
|
pubs.volume |
188 |
|
dc.date.updated |
2021-08-19T03:42:02Z |
|
dc.rights.holder |
Copyright: The author |
en |
pubs.author-url |
https://www.ncbi.nlm.nih.gov/pubmed/30508643 |
|
pubs.end-page |
7 |
|
pubs.publication-status |
Published |
|
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Research Support, Non-U.S. Gov't |
|
pubs.subtype |
Randomized Controlled Trial |
|
pubs.subtype |
Journal Article |
|
pubs.elements-id |
758251 |
|
dc.identifier.eissn |
1879-1220 |
|
dc.identifier.pii |
S0960-0760(18)30348-0 |
|